Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial

作者：Jordi Remón, Paolo Bironzo, Nicolas Girard, L. Bigay-Gamé, Óscar Juan, Javier de Castro, Noemı́ Reguart, Laurent Greillier, Sophie Cousin, Éric Dansin, Margarita Majem, Reyes Bernabé, Joaquin Mosquera Martinez, Marta Díaz, A. Meya, Daniel Alcalá-López, Alicia García‐Sanz, Luisella Righi, Silvia Novello, Benjamin Besse · 发表于：The Lancet Oncology · 年份：2025 · DOI：10.1016/s1470-2045(25)00300-6 · 被引用次数：8 · 研究领域：Myasthenia Gravis and Thymoma、Adrenal and Paraganglionic Tumors、Autoimmune Neurological Disorders and Treatments